Megan D. Montgomery, Ph.D. - Publications

Affiliations: 
2009 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Pharmacology

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Montgomery MD, Bylund DB. Lack of effect of the alpha2C-adrenoceptor Del322-325 polymorphism on inhibition of cyclic AMP production in HEK293 cells. British Journal of Pharmacology. 159: 820-30. PMID 20128806 DOI: 10.1111/J.1476-5381.2009.00584.X  0.457
2007 Bylund DB, Kozisek ME, Montgomery MD, Reed AL. Today's research, tomorrow's health: focus on pharmacogenomics. Personalized Medicine. 4: 363-367. PMID 29788667 DOI: 10.2217/17410541.4.3.363  0.386
2007 Deupree JD, Montgomery MD, Bylund DB. Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram. European Journal of Pharmacology. 576: 55-60. PMID 17850785 DOI: 10.1016/J.Ejphar.2007.08.017  0.447
2007 Montgomery MD, Taylor CK, Deupree JD, Bylund DB. Effect of alpha‐2C adrenergic receptor Del322‐325 polymorphism on cyclic AMP production in HEK293 cells The Faseb Journal. 21. DOI: 10.1096/fasebj.21.5.a423-c  0.444
Show low-probability matches.